Triggering and resolution of inflammation in NASH

By Susanne Schuster, D. Cabrera, M. Arrese, A. Feldstein. Nature reviews: Gastroenterology & hepatology, 2018

823 citations recorded by the source corpus.

Subfields: Cell Biology, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/9156f5a498e1c33309d57c35881fc1785fa0baf9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

1. Gerald I. Shulman
2. S. Friedman

In Endocrinology, Diabetes and Metabolism

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba

In Epidemiology

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba
4. Y. Saiman
5. J. Puche
6. J. Bonner
7. D. Clegg
8. B. Palmer

Citations in the corpus

• NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020, neutral): “48 49 Whereas it had been initially believed that mainly intrahepatic triglyceride accumulation might contribute to liver inflammation, several studies have highlighted other pathways that may increase inflammation.”
• Mechanisms and disease consequences of nonalcoholic fatty liver disease (2021, background): “Neutrophils have been overlooked until recently; however, their emergence asmediators of tissue inflammation and fibrosis resolution underscores their newfound importance in NASH pathogenesis (Musso et al., 2018; Schuster et al., 2018).”